Donors, Friends Support Brain Tumor Research at 15th Annual Minds Matter Benefit
Save the date for Minds Matter 2024!
Friday, May 10, 2024
720 S. Michigan Ave.
Chicago, IL 60605
More than 300 friends and philanthropists gathered May 5 to celebrate and support advancements in brain tumor research and care, raising over $500,000.
The Minds Matter benefit, held this year at The Ritz-Carlton in Chicago, is an annual fundraiser for the Lou and Jean Malnati Brain Tumor Institute (MBTI) of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital. Net proceeds support brain tumor research and patient care.
More than 700,000 people living today—and their families—face the challenging realities of a brain or spinal diagnosis. This year, the Northwestern Medicine team tested a novel, skull-implantable ultrasound device to open the blood-brain barrier and deliver chemotherapy that directly targets the aggressive tumors associated with glioblastoma. They also developed a new tool to help physicians predict the risk of blood clots in patients with adult-type diffuse gliomas and discovered a combination of treatments that extend progression-free survival in patients with recurrent glioblastoma.
“Once again, the annual Minds Matter benefit united our community of donors, patients and champions of the Malnati Brain Tumor Institute to support our mission of improving treatments and outcomes for brain and spine tumor patients in Chicago and beyond. We are deeply grateful for the opportunity to celebrate our successes as well as plan for a bright future,” said James P. Chandler, MD, co-director of MBTI and the Lavin/Fates Professor of Neurological Surgery.
Next year's event will take place on Friday, May 10, at the Hilton Chicago at 720 S. Michigan Ave. Additional information can be found here.
“Raising funds for brain tumor research is personal to me,” said Bill Evanoff, a member of the MBTI Advisory Council and chair of the Minds Matter host committee. “So many lives have been forever altered by this disease. But like so many others who have been impacted, I’ve also found true hope from the treatment innovations and research advancements made at the MBTI."
Still, Evanoff said, there is much more that must be done to keep the momentum going.
"Coming together year after year to fund brain tumor research—in addition to providing a wonderful, inspiring evening—is incredibly impactful on countless lives,” he said.
For more information about supporting Malnati Brain Tumor Institute, please contact Terri Dillon at email@example.com or 312-503-4837.
Pictured: Dean Harrison, executive chairman of Northwestern Memorial HealthCare; Jean and Marc Malnati of the Marc and Jeanne Malnati Family Foundation; Jean Malnati-Miller (front) of the Lou Malnati Cancer Research Foundation; Amy Heimberger, MD, PhD, co-director of the MBTI and the Jean Malnati Miller Professor of Brain Tumor Research; Roger Stupp, MD, co-director of the MBTI and the Paul C. Bucy Professor of Neurological Surgery; and James P. Chandler, MD, co-director of MBTI and the Lavin/Fates Professor of Neurological Surgery
Pictured: Bill and Viviane Evanoff, members of the MBTI Advisory Council